Aaron Levitt

InvestorPlace Contributor

Aaron Levitt is an independent investment analyst and author living in State College, Pennsylvania. His work appears in several high profile publications in both print and on the web.

As an advocate for long-term globally oriented investing, Aaron believes that exchange traded funds have leveled playing field for Main Street. Following global macro-economic trends, investors now have several avenues to create great long term portfolios.

Aaron is a graduate of The Pennsylvania State University where he studied Economics and International Business. Aside for helping regular investors develop winning portfolios, his current projects include writing his first book on alternative energy investing.

Follow his picks and pans on Twitter at @AaronLevitt.

Recent Articles

3 Big Reasons AMD Stock Is Just Starting Its Next Growth Surge

By Aaron Levitt, InvestorPlace Contributor Jun 7, 2019

Advanced Micro Devices has finally turned a corner and there's plenty to like about its future. Here are three big reasons why AMD stock could surge over the long haul.

5 Healthcare Stocks to Pick Up From the Wreckage

By Aaron Levitt, InvestorPlace Contributor Jun 6, 2019

These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.

3 Wonderful, But Ignored Vanguard ETFs

By Aaron Levitt, InvestorPlace Contributor Jun 5, 2019

With more than 80 funds available, Vanguard ETFs can be a powerful portfolio tool. Here are 3 ETFs that deserve a spot in your investments.

Can the CVS Shift to a Total Healthcare Company Really Work?

By Aaron Levitt, InvestorPlace Contributor Jun 4, 2019

CVS is making some great moves to win the healthcare war. But will it be enough to boost CVS stock over the long haul?

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor May 30, 2019

Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.